TYO:4530 Revenue

Hisamitsu Pharmaceutical Co. had revenue of 34.67B JPY in the quarter ending May 31, 2025, a decrease of -3.20%. This brings the company's revenue in the last twelve months to 154.86B, up 6.49% year-over-year. In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B with 10.09% growth.

Revenue (ttm)

154.86B

Revenue Growth

+6.49%

P/S Ratio

1.96

Revenue / Employee

55.33M

Employees

2,799

Market Cap

303.89B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2025	156.01B	14.30B	10.09%
Feb 29, 2024	141.71B	13.38B	10.42%
Feb 28, 2023	128.33B	8.14B	6.77%
Feb 28, 2022	120.19B	5.68B	4.96%
Feb 28, 2021	114.51B	-26.48B	-18.78%
Feb 29, 2020	Pro	Pro	Pro
Feb 28, 2019	Pro	Pro	Pro
Feb 28, 2018	Pro	Pro	Pro
Feb 28, 2017	Pro	Pro	Pro
Feb 29, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,196.22B
Takeda Pharmaceutical Company	4,480.25B
HOYA Corporation	876.09B
Daiichi Sankyo Company	1,924.68B
Otsuka Holdings	2,401.70B
Terumo	1,037.94B
Astellas Pharma	1,944.99B
Shionogi &	440.50B

Revenue Rankings